Protide Pharmaceuticals Inc (PPMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 08/31
| 08-1993 | 08-1992 | 08-1991 | 08-1990 | 08-1989 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -410 | -420 | -170 | -149 | N/A |
| Depreciation Amortization | 40 | 20 | 20 | 19 | N/A |
| Other Working Capital | N/A | N/A | N/A | 18 | N/A |
| Other Operating Activity | -20 | -80 | 100 | 4 | 0 |
| Operating Cash Flow | $-390 | $-480 | $-50 | $-108 | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | -11 | N/A |
| Other Investing Activity | 720 | -2,360 | -10 | 0 | 0 |
| Investing Cash Flow | $720 | $-2,360 | $-10 | $-11 | $N/A |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | -30 | 4,650 | 90 | 56 | 0 |
| Financing Cash Flow | $-30 | $4,650 | $90 | $56 | $N/A |
| Beginning Cash Position | 190 | 30 | 0 | 63 | N/A |
| End Cash Position | 490 | 1,830 | 30 | 0 | N/A |
| Net Cash Flow | $300 | $1,800 | $30 | $-63 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -390 | -480 | -50 | -108 | N/A |
| Free Cash Flow | -390 | -480 | -50 | -108 | 0 |